Lazaro Garcia, MD
Family Medicine · Miami, FLNPI 1598792707
Payments from drug & device makers
Across 442 payments — averaging $23,357 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$9.4M
- Currax Pharmaceuticals LLC$759K
- Bausch Health US, LLC$127K
- GSK$22K
- Bristol Myers Squibb$16K
- Biogen$3K
- plus $5K from 24 others
Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 209 | $9,391,722 |
| Currax Pharmaceuticals LLC | 18 | $758,942 |
| Bausch Health US, LLC | 57 | $127,415 |
| GSK | 31 | $21,544 |
| Bristol Myers Squibb | 4 | $15,982 |
| Biogen | 2 | $3,480 |
| Shionogi Inc | 1 | $1,620 |
| Boehringer Ingelheim | 30 | $876 |
| PTC Therapeutics, Inc. | 1 | $269 |
| UCB, Inc. | 8 | $248 |
| Johnson & Johnson | 13 | $244 |
| Bayer | 10 | $243 |
| Acadia Pharmaceuticals Inc | 5 | $200 |
| AstraZeneca | 9 | $197 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $174 |
| Lilly USA, LLC | 7 | $158 |
| Astellas Pharma US Inc | 4 | $85 |
| Amarin Pharma, Inc. | 4 | $80 |
| Novo Nordisk | 4 | $66 |
| Amgen | 3 | $50 |
| Abbott | 2 | $43 |
| AbbVie | 2 | $42 |
| Travere Therapeutics, Inc. | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27 |
| Merck | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Novartis | 1 | $21 |
| Corcept Therapeutics | 1 | $17 |
| Radius Health, Inc. | 1 | $13 |
How this compares
$10,323,866 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Miami
- Keila HooverMiami$33.7M
- Jorge CasoMiami$22.6M
- David WyattMiami$13.7M
- Jose CardenasMiami$13.2M
- Ibrahim Menendez PerezMiami$8.9M
- Aniel Navarro MarinMiami$7.3M
- Gilberto SecoMiami$6.8M
- Ramon LeonMiami$6.3M
- Eddy CapoteMiami$6.2M
- Erick JuarezMiami$5.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.